Deep 6 AI logo

Deep 6 AI

56 employees · est. 2015 · Pasadena, United States

VS
Massive Bio logo

Massive Bio

AI-driven system connecting cancer patients to clinical trials in real time. Industrializing the oncology action layer.

98 employees · est. 2014 · Istanbul, Turkey

Massive Bio is the older company (2015 vs 2014).

Side-by-Side Comparison

Deep 6 AI Massive Bio
Founded
2015 2014 older
Headquarters
Pasadena, United States Istanbul, Turkey
Employees
56 98
Industry
AI, Analytics, Health Care AI, Big Data, Biotechnology
Funding Stage
Series A Series B
Total Funding
$17.57M $28.10M
Funding Rounds
4 7
Services
AI-powered patient recruitment and precision matching for clinical trials AI-driven clinical trial matching, Cancer patient support, Tailored medical reports, Financial assistance exploration, Insurance coverage review
Target Customers
Healthcare organizations, life sciences companies, research institutions, clinical researchers Cancer patients, Physicians, Healthcare providers, Pharmaceutical companies, Clinical researchers
Taxonomy
AI-based Platform, Healthcare Analytics, Unstructured Data Analysis, Clinical Trial Patient Identification, Patient Recruitment, Artificial Intelligence, Natural Language Processing, Oncology Research, Neurology Research, Immuno-oncology Research, Software As A Service (SAAS) AI-driven Oncology Solutions, Clinical Trial Matching, Oncology Trial Enrollment, Real-world Evidence, Precision Oncology, Neurosymbolic Systems, Patient Enrollment Optimization, Cancer Genomics, Tumor Profiling Technologies, Drug Development Acceleration, Virtual Site Activation, Personalized Cancer Treatment, Patient Support Services, Cancer Research Partnerships, Healthcare Technology Innovation
Website
deep6.ai massivebio.com
Deep 6 AI logo

About Deep 6 AI

**Deep 6 AI** is a Pasadena-based startup founded in 2015, specializing in AI, analytics, healthcare, pharmaceuticals, and machine learning. The company disrupts the clinical trial enrollment process by leveraging artificial intelligence and natural language processing to quickly identify eligible p...

Massive Bio logo

About Massive Bio

Massive Bio, founded in 2014, is revolutionizing the oncology sector with its AI-driven system that connects cancer patients to clinical trials in real-time, thereby industrializing the oncology action layer. Operating in 17 countries across North America, Europe, and LATAM, this Turkey-headquartere...

We will tell you when either one moves

BounceWatch watches Deep 6 AI and Massive Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Deep 6 AI and Massive Bio — by email.

Frequently Asked Questions

Deep 6 AI. Massive Bio — AI-driven system connecting cancer patients to clinical trials in real time. Industrializing the oncology action layer.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Deep 6 AI has raised $17.57M while Massive Bio has raised $28.10M.
Deep 6 AI and Massive Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Deep 6 AI with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Deep 6 AI on 18 Feb 2025, and Massive Bio on 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy